Allarta Life Science Inc.: federal grants and contributions: 9 agreements; $1.1M value; 1 departments; 5 programs.
Assay record ASY-CA-1V6WPWN0TB · Cite as: Assay Systems, “Allarta Life Science Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/allarta-life-science-inc/
The current project advances the manufacturing readiness of Allarta’s Microgel Technology using scale-up engineering methodologies. Additionally, Allarta is extending the market penetration potential of its cell encapsulation devices through cold-chain solutions, allowing for the scale-up and commercial application of cell therapies beyond life-threatening illnesses which can bear the burden of ‘just-in-time’ production logistics.
Non-cell permeating microgels are developed to promote cryopreservation with limited or no use of DMSO. This project aims to develop degradable microgels that are easy to separate from cell suspensions post-thawing. The microgels are being developed to work with a wide variety of cells and cell clusters.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Cell-based therapies for chronic disorders such as Type 1 Diabetes hold the promise of curative treatments. This project aims to developing robust yet immune-evasive hydrogel capsules to enable islet transplants in a mouse model.
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The Project will support development of intellectual property capacity within the Firm.
To help identify gaps in Allarta's existing intellectual property portfolio
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.